Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.5200
+0.0300 (6.12%)
At close: Mar 19, 2026
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 26.95 million as of March 20, 2026. Its market cap has decreased by -0.72% in one year.
Market Cap
26.95M
Enterprise Value
23.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.52
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 26.95M, an increase of 93.15%. That is a compound annual growth rate of 18.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 26.95M | -20.00% |
| Dec 31, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 52.16M |
| MedMira | 45.33M |
| Defence Therapeutics | 44.60M |
| BriaCell Therapeutics | 42.92M |
| Microbix Biosystems | 34.56M |
| Devonian Health Group | 34.30M |
| Resverlogix | 31.62M |
| Telescope Innovations | 30.71M |